ICU Medical Inc (ICUI) — Analysis Summary
ICU Medical Inc (ICUI) has a market cap of $4.38B with year-over-year revenue growth of -6.3%. Net margin stands at 0.0%. The stock trades at a P/E ratio of -282.2.
Key Takeaways
- Revenue changed -6.3% year-over-year
- Net margin of 0.0%
- P/E ratio of -282.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, ICUI posted revenue growth of -6.3% and trades at a P/E of -282.2.
ICU Medical Inc (ICUI)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.9x — earnings do not cover interest payments
Net income turned negative after a profitable prior period.
Debt/EBITDA at 4.5x — elevated leverage
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
13,000
Headquarters
SAN CLEMENTE, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.